Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
Tel: +86-371- 86259723
Tel: 17734809689
Tel: 17734809689
Tel: 86-371-86259723
Tel: 17734809689
Tel: 17734809689
Mobile: 17734809689
Tel: +86-371- 86259723
Fax: +86-371- 86259723
Province/state: HENAN
City: ZHENGZHOU
Street: Mingmen International Center, NO.222 Dongming Road,Zhengzhou,Henan,China
MaxCard:
CAS NO.19767-45-4
Mesna Basic information |
Product Name: | Mesna |
Synonyms: | 2-mercaptoethanesulfonic;2-mercaptoethanesulfonicacidmonosodiumsalt;2-mercapto-ethanesulfonicacimonosodiumsalt;mesnum;mistabron;mitexan;mucofluid;uromitexan |
CAS: | 19767-45-4 |
MF: | C2H5NaO3S2 |
MW: | 164.18 |
EINECS: | 243-285-9 |
Product Categories: | Anti-Cancer;Pharmaceutical material and intermeidates;Xanthones;All Aliphatics;Antitumors for Research and Experimental Use;Biochemistry;Aliphatics;Sulfur & Selenium Compounds;CORDARONE;Anti-cancer&immunity |
Mol File: | 19767-45-4.mol |
Mesna Chemical Properties |
mp | >240°C dec. |
storage temp. | -20 C Freezer, Under Inert Atmosphere |
Merck | 5909 |
Stability: | Stable. Incompatible with strong oxidizing agents. |
CAS DataBase Reference | 19767-45-4(CAS DataBase Reference) |
Safety Information |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
WGK Germany | 2 |
RTECS | KI7968000 |
MSDS Information |
Provider | Language |
---|---|
SigmaAldrich | English |
Mesna Usage And Synthesis |
Chemical Properties | White to Off-White Solid |
Usage | adrenergic agonist, coronary vasodilator, Ca channel blocker |
Usage | Mesna reacts with acrolein and other urotoxic metabolites of oxazaphosphorines (cyclophosphamide or ifosfamide) to form stable, non-urotoxic compounds. Mesna does not have any antitumour activity, nor does it appear to interfere with the antitumour activity of antineoplastic drugs. This medication is used to protect the bladder wall from the harmful effects of some cancer-fighting drugs. |
Mesna Preparation Products And Raw materials |
Mesna Basic information |
Product Name: | Mesna |
Synonyms: | 2-mercaptoethanesulfonic;2-mercaptoethanesulfonicacidmonosodiumsalt;2-mercapto-ethanesulfonicacimonosodiumsalt;mesnum;mistabron;mitexan;mucofluid;uromitexan |
CAS: | 19767-45-4 |
MF: | C2H5NaO3S2 |
MW: | 164.18 |
EINECS: | 243-285-9 |
Product Categories: | Anti-Cancer;Pharmaceutical material and intermeidates;Xanthones;All Aliphatics;Antitumors for Research and Experimental Use;Biochemistry;Aliphatics;Sulfur & Selenium Compounds;CORDARONE;Anti-cancer&immunity |
Mol File: | 19767-45-4.mol |
Mesna Chemical Properties |
mp | >240°C dec. |
storage temp. | -20 C Freezer, Under Inert Atmosphere |
Merck | 5909 |
Stability: | Stable. Incompatible with strong oxidizing agents. |
CAS DataBase Reference | 19767-45-4(CAS DataBase Reference) |
Safety Information |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36 |
WGK Germany | 2 |
RTECS | KI7968000 |
MSDS Information |
Provider | Language |
---|---|
SigmaAldrich | English |
Mesna Usage And Synthesis |
Chemical Properties | White to Off-White Solid |
Usage | adrenergic agonist, coronary vasodilator, Ca channel blocker |
Usage | Mesna reacts with acrolein and other urotoxic metabolites of oxazaphosphorines (cyclophosphamide or ifosfamide) to form stable, non-urotoxic compounds. Mesna does not have any antitumour activity, nor does it appear to interfere with the antitumour activity of antineoplastic drugs. This medication is used to protect the bladder wall from the harmful effects of some cancer-fighting drugs. |
Mesna Preparation Products And Raw materials |